Please assess the completion status of the following clinical trial:

Trial Title: Treatment Strategy for Low-grade Gliomas

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically confirmed newly diagnosed low-grade gliomas~* Karnofsky performance status of 60 or more~Exclusion Criteria:~* Previous history of radiation therapy or chemotherapy for gliomas~* Pregnant or breast feeding~* Diagnosis of another malignancy may exclude subject from study~* Evidence or history of bleeding diathesis~* Evidence or history of hypersensitivity to temozolomide

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Total resection with early radiation (Type: EXPERIMENTAL): Total resected LGGs treated with early radiation
- Total resection without radiation (Type: NO_INTERVENTION): Total resected LGGs treated without radiation
- Residual LGGs with radiation (Type: EXPERIMENTAL): Residual LGGs treated with early radiation
- Residual LGGs with chemo (Type: EXPERIMENTAL): Residual LGGS treated with temozolomide

Based on this trial design, predict the completion outcome and termination type (if applicable).